Showing results (1721-1730 of 2,081) with videos related to

Sort By:
Pageof 209
Transplantation and Cellular Therapy|July 12, 2024
Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage ChemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.
Leukemia & Lymphoma|October 27, 2006
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N M Micallef, Ellen D Remstein, Stephen M Ansell, et al.
RMD Open|October 10, 2022
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccinationElisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, et al.
Cell Metabolism|May 3, 2011
MTERF4 regulates translation by targeting the methyltransferase NSUN4 to the mammalian mitochondrial ribosomeYolanda Cámara, Jorge Asin-Cayuela, Chan Bae Park, et al.
Nature Cell Biology|November 13, 2007
Genome-scale RNAi profiling of cell division in human tissue culture cellsRalf Kittler, Laurence Pelletier, Anne-Kristine Heninger, et al.
Bladder (San Francisco, Calif.)|August 11, 2020
Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysisTyler J Wilhite, David Routman, Andrea L Arnett, et al.
Blood|November 26, 2014
Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphomaMuhammad A Mir, Matthew J Maurer, Steven C Ziesmer, et al.
Hematological Oncology|October 28, 2022
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphomaSanjal H Desai, Raphael Mwangi, Alexandra N Smith, et al.
Nuclear Medicine and Biology|April 29, 2014
Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humansMarianne Patt, Georg A Becker, Udo Grossmann, et al.
Haematologica|January 18, 2024
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.
Pageof 209